IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...

Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Radius VSM™, a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance. Designed on ...

Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...

Masimo, a lead developer of patient sensing and monitoring technology, has expanded its two decade long partnership with Royal Philips. The two have also renewed their partnership for several more ...

Danaher said Tuesday it has agreed to acquire patient monitoring company Masimo for $9.9 billion to bolster its diagnostics franchise. Masimo will become a standalone business unit and brand within ...

Medical technology company Masimo on Wednesday filed a lawsuit against U.S. Customs and Border Protection in which it challenged the agency's decision to allow Apple to restore blood oxygen monitoring ...

Masimo develops advanced noninvasive monitoring technologies used by hospitals and healthcare providers worldwide.